The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
Authors
Lim, K. H. J.Punie, K.
Oing, C.
Thorne, E.
Murali, K.
Kamposioras, Konstantinos
O'Connor, M.
Elez, E.
Amaral, T. M. S.
Lopez, P. G.
Lambertini, M.
Devnani, B.
Westphalen, C. B.
Morgan, G.
Haanen, J.
Hardy, C.
Banerjee, S.
Affiliation
Department of Immunology and Inflammation, Imperial College London & The Francis Crick Institute, London, UKIssue Date
2021
Metadata
Show full item recordAbstract
Background The ESMO Resilience Task Force has investigated wellbeing since COVID-19 in relation to work, lifestyle and support factors in oncology professionals globally. We reported on the significant impact of the initial surge of the pandemic on wellbeing and job performance (Banerjee et al. 2021). As the pandemic continues, it is imperative to understand experiences and concerns to better inform support measures for the oncology workforce. Methods Three anonymous online surveys were conducted during the COVID-19 pandemic (S1, Apr/May 2020; S2, Jul/Aug 2020; S3, Feb/Mar 2021). Longitudinal analysis of responses at these timepoints were conducted. Here, we present responses to questions on job demands and resources, and perceived job performance since COVID-19 (JP-CV). Results We analysed 3894 individual responses (S1, n=1520; S2, n=942; S3, n=1432): 53% (n=1961/3731) female, 45% (n=1679/3731) =/<40 years, 31% (n=1132/3692) non-white ethnicity, >100 countries. There has been significant increases from S1 to S3 (p<0.001) in feeling overwhelmed with workload (29% vs 45%); COVID-19-related clinical (14% vs 58%) and research (16% vs 64%) work; out-of-hours work (16% vs 41%), shift work (12% vs 26%) and overall working hours (17% vs 47%); and inadequate time for personal/family life (35% vs 45%). 59% (n=1156/1946) were unable to take allocated annual leave. While JP-CV has improved (34% vs 49%, p<0.001), there remained concerns about the negative impact of the pandemic on career development/training (43%), job security (37%) and international fellowship opportunities (76%). Overall, less than half had felt supported by their work management, professional societies or government, and/or had access to wellbeing support services. 25% (n=266/1086) were considering changing their future career with 38% (n=100/266) contemplating leaving the profession. Conclusions Since COVID-19, oncology professionals have reported increased job demands, concerns over career development/training and job security, and inadequate time for personal life. There is a real threat of potential attrition in the current workforce. National and international stakeholders must act together to ensure robust recovery plans as we emerge from the COVID-19 crisis.Citation
Lim KHJ, Punie K, Oing C, Thorne E, Murali K, Kamposioras KV, et al. 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series. Vol. 32, Annals of Oncology. Elsevier BV; 2021. p. S1130�1.Journal
Annals of OncologyDOI
10.1016/j.annonc.2021.08.1554Additional Links
https://dx.doi.org/10.1016/j.annonc.2021.08.1554Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2021.08.1554